{"zip": "659-0021", "sector": "Healthcare", "fullTimeEmployees": 667, "longBusinessSummary": "JCR Pharmaceuticals Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products, regenerative medicines, and drug substances primarily in Japan. The company offers GROWJECT, a recombinant human growth hormone for the treatment of short stature; Agalsidase Beta BS I.V. Infusion, a biosimilar for agalsidase beta for the treatment of Fabry disease, a type of lysosomal storage disorder; and TEMCELL HS Inj, a therapeutic product using mesenchymal stem cells for the treatment of acute graft-versus-host disease. It also develops biosimilar products for the treatment of renal anemia. The company was founded in 1975 and is headquartered in Ashiya, Japan.", "city": "Ashiya", "phone": "81 7 9732 8591", "country": "Japan", "companyOfficers": [], "website": "http://www.jcrpharm.co.jp", "maxAge": 1, "address1": "3-19 Kasuga-cho", "industry": "Drug Manufacturers\u2014General", "previousClose": 2948, "regularMarketOpen": 2969, "twoHundredDayAverage": 2917.273, "trailingAnnualDividendYield": 0.0029681139, "payoutRatio": 0.66760004, "volume24Hr": null, "regularMarketDayHigh": 3025, "navPrice": null, "averageDailyVolume10Day": 729150, "totalAssets": null, "regularMarketPreviousClose": 2948, "fiftyDayAverage": 3431.111, "trailingAnnualDividendRate": 8.75, "open": 2969, "averageVolume10days": 729150, "expireDate": null, "yield": null, "algorithm": null, "dividendRate": 22.5, "exDividendDate": 1617062400, "beta": 0.174322, "circulatingSupply": null, "startDate": null, "regularMarketDayLow": 2940, "priceHint": 2, "currency": "JPY", "trailingPE": 87.998795, "regularMarketVolume": 630000, "lastMarket": null, "maxSupply": null, "openInterest": null, "marketCap": 361688760320, "volumeAllCurrencies": null, "strikePrice": null, "averageVolume": 1239434, "priceToSalesTrailing12Months": 13.842957, "dayLow": 2940, "ask": 0, "ytdReturn": null, "askSize": 0, "volume": 630000, "fiftyTwoWeekHigh": 3800, "forwardPE": 20.331347, "fromCurrency": null, "fiveYearAvgDividendYield": 0.55, "fiftyTwoWeekLow": 2336, "bid": 0, "tradeable": false, "dividendYield": 0.0076, "bidSize": 0, "dayHigh": 3025, "exchange": "JPX", "shortName": "JCR PHARMACEUTICAL CO", "longName": "JCR Pharmaceuticals Co., Ltd.", "exchangeTimezoneName": "Asia/Tokyo", "exchangeTimezoneShortName": "JST", "isEsgPopulated": false, "gmtOffSetMilliseconds": "32400000", "underlyingSymbol": null, "quoteType": "EQUITY", "symbol": "4552.T", "underlyingExchangeSymbol": null, "headSymbol": null, "messageBoardId": "finmb_1040458", "uuid": "0f381962-4ea3-31b1-8820-a060da47c0f2", "market": "jp_market", "annualHoldingsTurnover": null, "enterpriseToRevenue": 13.958, "beta3Year": null, "profitMargins": 0.15833999, "enterpriseToEbitda": 55.531, "52WeekChange": null, "morningStarRiskRating": null, "forwardEps": 144.26, "revenueQuarterlyGrowth": null, "sharesOutstanding": 123317000, "fundInceptionDate": null, "annualReportExpenseRatio": null, "bookValue": 280.807, "sharesShort": null, "sharesPercentSharesOut": null, "fundFamily": null, "lastFiscalYearEnd": 1585612800, "heldPercentInstitutions": 0.10512, "netIncomeToCommon": 4136999936, "trailingEps": 33.33, "lastDividendValue": null, "SandP52WeekChange": null, "priceToBook": 10.444896, "heldPercentInsiders": 0.50081, "nextFiscalYearEnd": 1648684800, "mostRecentQuarter": 1609372800, "shortRatio": null, "sharesShortPreviousMonthDate": null, "floatShares": 64838045, "enterpriseValue": 364683821056, "threeYearAverageReturn": null, "lastSplitDate": 1601424000, "lastSplitFactor": "4:1", "legalType": null, "morningStarOverallRating": null, "earningsQuarterlyGrowth": 1.307, "dateShortInterest": null, "pegRatio": null, "lastCapGain": null, "shortPercentOfFloat": null, "sharesShortPriorMonth": null, "category": null, "fiveYearAverageReturn": null, "regularMarketPrice": 2933, "logo_url": "https://logo.clearbit.com/jcrpharm.co.jp"}